BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10659750)

  • 1. Toward a statistically relevant calibration end point for prostate seed implants.
    Rosenzweig DP; Schell MC; Yu Y
    Med Phys; 2000 Jan; 27(1):144-50. PubMed ID: 10659750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds.
    Nath S; Chen Z; Yue N; Trumpore S; Peschel R
    Med Phys; 2000 May; 27(5):1058-66. PubMed ID: 10841410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
    Butler WM; Merrick GS; Dorsey AT; Lief JH
    Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCPI: a sub-minute Monte Carlo dose calculation engine for prostate implants.
    Chibani O; Williamson JF
    Med Phys; 2005 Dec; 32(12):3688-98. PubMed ID: 16475768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
    Chen Z; Nath R
    Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric and volumetric criteria for selecting a source activity and a source type ((125)I or (103)Pd) in the presence of irregular seed placement in permanent prostate implants.
    Wuu CS; Ennis RD; Schiff PB; Lee EK; Zaider M
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):815-20. PubMed ID: 10837969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic algorithm for the optimization of prostate implants.
    Yu Y; Schell MC
    Med Phys; 1996 Dec; 23(12):2085-91. PubMed ID: 8994175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo-aided dosimetry of the Symmetra model I25.S06 125I, interstitial brachytherapy seed.
    Hedtjärn H; Carlsson GA; Williamson JF
    Med Phys; 2000 May; 27(5):1076-85. PubMed ID: 10841412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of seed loading approaches in prostate brachytherapy.
    Butler WM; Merrick GS; Lief JH; Dorsey AT
    Med Phys; 2000 Feb; 27(2):381-92. PubMed ID: 10718143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric parameters for three low-energy brachytherapy sources using the Monte Carlo N-particle code.
    DeMarco JJ; Hugo G; Solberg TD
    Med Phys; 2002 May; 29(5):662-8. PubMed ID: 12033560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal prostate brachytherapy with (103)Pd seeds.
    Butler WM; Merrick GS
    Phys Med; 2016 Mar; 32(3):459-64. PubMed ID: 27053451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Well-ionization chamber response relative to NIST air-kerma strength standard for prostate brachytherapy seeds.
    Mitch MG; Zimmerman BE; Lamperti PJ; Seltzer SM; Coursey BM
    Med Phys; 2000 Oct; 27(10):2293-6. PubMed ID: 11099196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
    Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
    Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment planning considerations and quality assurance for CT-guided transischiorectal implantation of the prostate.
    Molloy JA; Williams MB
    Med Phys; 1999 Sep; 26(9):1943-51. PubMed ID: 10505884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 103Pd brachytherapy dose prescription.
    Wallace RE
    Med Phys; 1999 Sep; 26(9):2034-5. PubMed ID: 10505895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.